4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
6.67
+0.52 (8.46%)
At close: Aug 13, 2025, 4:00 PM
6.42
-0.25 (-3.75%)
Pre-market: Aug 14, 2025, 9:16 AM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $311.51 million as of August 14, 2025. Its market cap has decreased by -67.17% in one year.
Market Cap
311.51M
Enterprise Value
-82.45M
1-Year Change
-67.17%
Ranking
Category
Stock Price
$6.67
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $311.51M, a decrease of -46.33%. That is a compound annual growth rate of -12.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 287.22M | 11.55% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 572.40B |
| Johnson & Johnson | 414.64B |
| AbbVie | 350.33B |
| UnitedHealth Group | 234.72B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.97B |
| Novo Nordisk | 222.88B |